Get the Stockscreener App
18.83
1.77%
-0.34
After Hours:
18.80
-0.03
-0.16%
Adma Biologics Inc stock is traded at $18.83, with a volume of 2.38M.
It is down -1.77% in the last 24 hours and up +22.11% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$19.17
Open:
$19.03
24h Volume:
2.38M
Relative Volume:
0.70
Market Cap:
$4.48B
Revenue:
$474.17M
Net Income/Loss:
$208.93M
P/E Ratio:
22.17
EPS:
0.8493
Net Cash Flow:
$65.61M
1W Performance:
-5.76%
1M Performance:
+22.11%
6M Performance:
-0.32%
1Y Performance:
+1.07%
1-Day Range:
$18.42
$19.05
1-Week Range:
$18.33
$20.46
52-Week Range:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
18.83 | 4.56B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - MSN
Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Does ADMA’s Upgraded EPS Outlook And Higher-Yield Manufacturing Change The Bull Case For ADMA Biologics (ADMA)? - Sahm
ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P. - MarketBeat
Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Precision Trading with Adma Biologics Inc (ADMA) Risk Zones - news.stocktradersdaily.com
ADMA Biologics Inc $ADMA Holdings Decreased by AWM Investment Company Inc. - MarketBeat
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - MSN
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management - MarketBeat
Federated Hermes Inc. Has $17.06 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Arrowstreet Capital Limited Partnership Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ophir Asset Management Pty Ltd Boosts Position in ADMA Biologics Inc $ADMA - MarketBeat
WINTON GROUP Ltd Has $4.97 Million Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Will ASCENIV Momentum and FDA-Cleared Yield Gains Change ADMA Biologics' (ADMA) Narrative? - Sahm
Is ADMA Biologics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
What analysts say about ProShares Trust ProShares Ultra Financials stockHigh Yield Income Stocks & Small Investment Capital Gains - earlytimes.in
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue? - sharewise.com
Stonepine Capital Management LLC Sells 60,000 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - MSN
Technical Reactions to ADMA Trends in Macro Strategies - news.stocktradersdaily.com
Rhumbline Advisers Buys 30,391 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Looks Just Right With A 25% Price Jump - simplywall.st
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - sharewise.com
Legal & General Group Plc Acquires 37,699 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Northwest & Ethical Investments L.P. Has $425,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Elo Mutual Pension Insurance Co Buys 25,267 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Russell Investments Group Ltd. Acquires 186,835 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Advantage Alpha Capital Partners LP Sells 62,257 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Published on: 2025-11-29 10:13:00 - moha.gov.vn
What analysts say about ADMA Biologics Inc stockMarket Sentiment Report & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in
Ensign Peak Advisors Inc Acquires 80,462 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Guidance Update: How ADMA Biologics Inc. stock valuations compare to rivals2025 AllTime Highs & Fast Gain Swing Alerts - moha.gov.vn
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet - Zacks Investment Research
Dynamic Technology Lab Private Ltd Buys New Shares in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves - Sahm
Where Will Sharp Investments Limited Stock Be in YEAR5 Growth ForecastExit Strategy Tips & These Stocks Are Just Getting Started - earlytimes.in
American Century Companies Inc. Buys 358,627 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average - sharewise.com
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - sharewise.com
What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga
High Growth Tech Stocks In The US For November 2025 - Yahoo Finance
Arihant Foundations Housing Limited Testing Reversal Zone on Weekly ChartLong-Term Growth Stocks & Breakout Stock Alerts - earlytimes.in
Intech Investment Management LLC Cuts Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa
ADMA Biologics CEO Adam S Grossman Sells Shares - TradingView
[Form 4] ADMA BIOLOGICS, INC. Insider Trading Activity - Stock Titan
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):